ESC WG on CPM Chairperson

Official X account of the @escardio Working Group on Coronary Pathophysiology & Microcirculation Chairperson.
Posts by Edina Cenko and her team. #WGCPM_ESC

[EHJ Editor-in-Chief @ehj_ed]

Coronary microvascular obstruction: the "no-reflow" problem that haunts STEMI care. New ESC clinical consensus on pathophysiology, prevention & management: a must-read. Read more in #EHJ.
https://t.co/WWlcFSfVyj
#cardiotwitter @ESC_Journals @escardio

[EAPCIPresident @EAPCIPresident]

Just published on @ESC_Journals

Intracoronary imaging for left main percutaneous coronary intervention: a clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC and the European Bifurcation Club (EBC) https://t.co/Fe6iDNuwZD

[Women As One @WomenAs1]

Does physician sex influence CV outcomes?

This article reviews evidence suggesting outcome differences may exist across settings, highlighting possible links to communication, guideline use, and care delivery, while noting the complexity of causality.

https://t.co/c7LGXK9GGN

[European Society of Cardiology @escardio]

The European Society of Cardiology is deeply saddened by the passing of Professor Eugene Braunwald, one of the most influential figures in the history of cardiovascular medicine, who died on 22 April 2026, aged 96.

“Professor Braunwald was the leading cardiologist of his time. His vision and innovation changed the trajectory of cardiovascular medicine. He had a rare ability to see what the field needed next, and then to build the science and rigorous evidence leading to better care. He set a standard for intellectual honesty and mentorship, giving generations of clinicians and researchers the confidence to aim higher.” Professor Thomas F. Lüscher, @ESC_President

Professor Braunwald’s work helped define how cardiovascular disease is understood and treated. His legacy endures in the patients whose lives have been saved by evidence-based cardiovascular care, and in the people he inspired to pursue medicine with integrity and purpose https://t.co/IUtVSlbzph

[Edina Cenko @EdinaCenko]

Rethink beta-blockers for uncomplicated hypertension?

Our @HyperAHA commentary: despite guideline upgrades evidence for routine use in uncomplicated cases is limited

👉 https://t.co/VJmEEBcKqM

[Prof Chris P Gale @cpgale3]

🤫, should one withhold beta-blockers after #heartattack?

Some reasons to be cautious…

https://t.co/U1pAuiton9

[Edina Cenko @EdinaCenko]

Upcoming online talk on a relevant topic

Register for free 👇
🔗 https://t.co/EDkeRSFrYd

@WGCPMChair @escardio @ItaloPorto2 @SIC_CARDIOLOGIA

[ESC WG on CPM Chairperson @WGCPMChair]

Persistent angina after revascularisation? 🫀

Join the @escardio #WGCPM_ESC & WGCARE_ESC for a free webinar on Residual vs. Refractory Angina
Explore strategies for your toughest cases

📅 29 May | 16:00 CEST
🔗 https://t.co/33mFdPWtMe

@EdinaCenko @ItaloPorto2 @RiSanz2020

[ESC WG on CPM Chairperson @WGCPMChair]

Physician sex may impact CV outcomes?

We must adopt practices that save lives: better communication, bias awareness, diverse clinical teams & leadership

Read more: https://t.co/1rgXNMA4ni

@EdinaCenko @ESCWGAVBChair @WGCPMChair @Drroxmehran @escardio @WomenAs1

[ESC WG on CPM Chairperson @WGCPMChair]

#FCVB2026
📅 17–19 April 2026
📍 Leuven Belgium
The #ESC flagship congress for translational CV medicine returns!

🤝 Highly interactive scientific programme
🔗 Registration: https://t.co/ji1QGpsUXN

#CardiovascularResearch @escardio @ESCWGAVBChair @WGCPMChair

[Women As One @WomenAs1]

Women’s heart health remains at risk as gaps in sex-specific research, male-focused diagnostics, and low trial enrollment contribute to underdiagnosis and undertreatment.

Sex-specific studies are vital to advance care and equity in cardiology.

Read more: https://t.co/JiD7eXyoH8

[@OSTOLab @OSTOLab1]

A new article in the European Heart Journal highlights an important dimension of cardiovascular care: “Cardiovascular disease outcomes: does physician’s sex matter?” Click on the link to learn more about this interesting topic!
https://t.co/rhlfTTImdw

[ESC WG on CPM Chairperson @WGCPMChair]

💡 New #WGCPM_ESC Newsletter
@arturocesaro Prof Paolo Calabrò & @vincenzoacerbo on the PPG Global Registry

Predictive physiology > anatomy
📉 PPG (0=diffuse 1=focal) predicts PCI success:
✅ Post-PCI FFR & 1-yr TVF
✅ Detects “physiological futility”

👉https://t.co/gKk4RPbcRc

[Elmir Omerovic @elmir1omerovic]

Check out my latest article: What Happens After the Trial Ends? https://t.co/qxYxeCp81V via @LinkedIn

[Edina Cenko @EdinaCenko]

Grouping risk factors masks danger?
New data in #EHJCCO: Diabetes drives 30-day ACS mortality but lumping factors dilute the risk
Risk +40% Men +29% #women
👉https://t.co/9P1KnnVPyn

Individualized assessment is key

#ISACS @OliviaManfrini @RBugiardini @EdinaCenko @maria_bergami

[ESC WG on CPM Chairperson @WGCPMChair]

New #WGCPM_ESC #ACVC_ESC #EAPCI statement on #sex & #gender differences in #IHD, including high-risk cardiogenic shock & emerging topics like gender-affirming therapies & CV risk

👉 https://t.co/kwmKk4xlJa

@ehj_ed @escardio @EdinaCenko @EAPCIPresident @ACVCPresident

[ESC WG on CPM Chairperson @WGCPMChair]

New #WGCPM_ESC #ACVC_ESC #EAPCI statement on #sex & #gender differences in #IHD, including high-risk cardiogenic shock & emerging topics like gender-affirming therapies & CV risk

👉 https://t.co/kwmKk4xlJa

@ehj_ed @escardio @EdinaCenko @EAPCIPresident @ACVCPresident

[Abdulla A. Damluji, MD, PhD @DrDamluji]

Sex and gender differences in coronary pathophysiology and ischaemic heart disease: A Scientific Statement of the ESC Working Group on Coronary Pathophysiology & Microcirculation, the Association for Acute CardioVascular Care, and the European Association of Percutaneous Cardiovascular Interventions of the ESC: @ESC_Journals

👇👇👇

[EHJ Editor-in-Chief @ehj_ed]

New ESC Scientific Statement sheds light on how sex and gender shape coronary disease risk, symptoms, diagnosis, and treatment, highlighting gaps in research and care and calling for more equitable heart health for all. Read more in #EHJ. https://t.co/IDs1c8mcXA
#cardiotwitter @ESC_Journals @escardio

[Prof Chris P Gale @cpgale3]

Challenges in the prevention, treatment & management of cardiovascular disease among older adults.

One of the many articles from our @LancetRH_Europe series….

@RBugiardini @DrMarthaGulati @EdinaCenko

https://t.co/Hs0zr3tH18